EVTM and COVID-19: today and tomorrow Traumatic thoracic aortic injuries Training for REBOA Embolization for post-partum bleeding Glue and Onyx: a practical guide REBOA for safe veno-arterial ECMO decannulation ECMO for penetrating thoracic injuries And more... EDITOR IN CHIEF

The abstract should be a maximum of 250 words and consist of the following headings: Background Methods Results Conclusions Original Studies Manuscripts reporting unique scientific studies should be no longer than 3000 words. They should consist of the following sections: • Introduction: This should concisely present the background to the problem that the study hopes to answer. A hypothesis should be clearly stated. • Methods: This section should be suitably detailed to permit replication of the study. The regulatory permissions for the study should also be detailed, e.g. Institutional Review Board, ethical committee etc. including a protocol/registration number. Where animal research has been undertaken, the institutional animal care and use guidelines that have been followed should be clearly stated. • Results: These should involve the reporting of the salient positive and negative findings of the study in clear language. The use of images, figures and tables are encouraged, of which the data should not be duplicated in the prose. There is no maximum number of figures or tables, but these should be appropriate to the study. should be reported to three decimal places. • Discussion: This should place the reported study findings in the context of the literature. Limitations and future direction should also be discussed. Authors must be careful to ensure that conclusions are not overstated and are supported by data. Editorials Short, focused Editorials on an important aspect of endovascular hemorrhage control are welcomed. These should endeavor to bring attention to an important topic, or accompany an article published within the journal. The latter will be invited by the Editor. Submitted manuscripts should be no longer than 1500 words. Narrative Review Articles This style of article can afford the author considerable latitude in examining a pertinent topic in endovascular hemorrhage control. The literature should be examined objectively and presented to the reader in the context of current understanding. The author should be able to synthesize a narrative, which leaves the reader with a good understanding of an emerging or controversial topic. The author is welcome (and encouraged) to express an opinion, but where this is the case, it should be clearly stated. Articles should be a maximum of 5000 words. There is no formal structure; however, the use of logical headings/subheadings is important to enable readers to follow the article easily. The abstract should also be unstructured and be a maximum of 150 words. Systematic Reviews and Meta-Analyses Where there is a topic within the subject area of endovascular hemorrhage control that has a substantial evidence base, a Systematic Review with/without a Meta-Analysis is considered more appropriate than a narrative review article. These articles should follow the methodology established by PRISMA. Submission should be a maximum of 5000 words and authors should include a PRISMA checklist in their submission. The overall aim is to provide a pooled analysis that enables firm conclusions to be drawn on a particular subject. Tips and Techniques In the evolving world of endovascular hemorrhage control, 1the advice and opinion of actively practicing clinicians is of great importance. Both solicited and unsolicited submissions are reviewed, both on major or minor components on endovascular techniuqes. This can be presented in the context of â€œevidenceâ€ or just as an opinion. The use of quality images and diagrams is encouraged. The submission should be a maximum of 1500 words.